Ra Capital Management, L.P. Day One Biopharmaceuticals, Inc. Transaction History
Ra Capital Management, L.P.
- $6.64 Billion
- Q2 2024
A detailed history of Ra Capital Management, L.P. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 7,871,721 shares of DAWN stock, worth $111 Million. This represents 1.63% of its overall portfolio holdings.
Number of Shares
7,871,721Holding current value
$111 Million% of portfolio
1.63%Shares
6 transactions
Others Institutions Holding DAWN
# of Institutions
167Shares Held
71.7MCall Options Held
163KPut Options Held
183K-
Atlas Venture Life Science Advisors, LLC6.43MShares$90.9 Million11.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$65.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$64.1 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.78MShares$53.4 Million0.02% of portfolio
-
Braidwell LP Stamford, CT3.04MShares$42.9 Million1.31% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.04B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...